Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Genomic Predictors Report Likely Response to Multiple Treatments in Breast Cancer
May 1st, 2007
Researchers at Nuvera Biosciences and The University of Texas M.D. Anderson Cancer Center have developed predictors of response to chemotherapy and hormonal treatments in breast cancer patients. Results of these studies will be announced at the Annual AACR Meeting in Los Angeles, CA. "It is exciting that the tests can identify not only high responders to standard treatments but also which non-responders to hormonal treatment might benefit most from chemotherapy," said lead author Christos Hatzis, Ph.D., VP, Technology at Nuvera. In previously described studies, a chemoresponse predictor was developed and validated from prospective samples of women...
Source: Cancer Weekly (2007-05-01)
|
